Neolabs is a decentralized science (DeSci) platform that merges blockchain technology with biotech research, enabling transparent, community-driven drug discovery. Researchers use it to tokenize IP and secure funding, while investors and patients benefit from early access to breakthroughs. By removing institutional barriers, it accelerates innovation, benefiting scientists, startups, and global health advocates seeking open, collaborative solutions.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends